Chk1 and Wee1 control genotoxic-stress induced G2-M arrest in melanoma cells

Cellular Signalling

Volumn 27, Issue 5, 2015, Pages 951-960

  Vera, Julio ^a   Raatz, Yvonne ^b   Wolkenhauer, Olaf ^c   Kottek, Tina ^b   Bhattacharya, Animesh ^b   Simon, Jan C ^b   Kunz, Manfred ^b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b UNIVERSITY OF LEIPZIG   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Cell cycle; Cell signalling; Chk1; Tumour biology; Wee1

Indexed keywords

CHECKPOINT KINASE 1; DOXORUBICIN; PROTEIN KINASE; PROTEIN P21; PROTEIN P53; PROTEIN WEE1; UNCLASSIFIED DRUG; ANTINEOPLASTIC ANTIBIOTIC; CDK1 PROTEIN, HUMAN; CELL CYCLE PROTEIN; CYCLIN DEPENDENT KINASE; NUCLEAR PROTEIN; PROTEIN TYROSINE KINASE; WEE1 PROTEIN, HUMAN;

APOPTOSIS; ARTICLE; CELL CYCLE ARREST; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE REGULATION; CELL STRESS; CONTROLLED STUDY; DNA DAMAGE; ENZYME INHIBITION; FIBROBLAST; GENOTOXICITY; HUMAN; HUMAN CELL; IMMUNOBLOTTING; MELANOMA CELL; MUTANT; PRIORITY JOURNAL; WILD TYPE; DRUG EFFECTS; G2 PHASE CELL CYCLE CHECKPOINT; GENETICS; M PHASE CELL CYCLE CHECKPOINT; MELANOMA; METABOLISM; PATHOLOGY; SIGNAL TRANSDUCTION; TUMOR CELL LINE;

ANTIBIOTICS, ANTINEOPLASTIC; APOPTOSIS; CELL CYCLE PROTEINS; CELL LINE, TUMOR; CYCLIN-DEPENDENT KINASES; DNA DAMAGE; DOXORUBICIN; G2 PHASE CELL CYCLE CHECKPOINTS; HUMANS; M PHASE CELL CYCLE CHECKPOINTS; MELANOMA; NUCLEAR PROTEINS; PROTEIN KINASES; PROTEIN-TYROSINE KINASES; SIGNAL TRANSDUCTION; TUMOR SUPPRESSOR PROTEIN P53;

EID: 84925467402     PISSN: 08986568     EISSN: 18733913     Source Type: Journal    
DOI: 10.1016/j.cellsig.2015.01.020     Document Type: Article

References (47)

1. Miller A.J., Mihm M.C. N. Engl. J. Med. 2006, 355:51-65. (PMID:16822996).
2. Garbe C., Eigentler T.K., Keilholz U., Hauschild A., Kirkwood J.M. Oncologist 2011, 16(1):5-24. (PMID:21212434). 10.1634/theoncologist. 2010-0190.
3. Hersey P., Bastholt L., Chiarion-Sileni V., Cinat G., Dummer R., Eggermont A.M., Espinosa E., Hauschild A., Quirt I., Robert C., Schadendorf D. Ann. Oncol. 2009, 20(Suppl. 6):vi35-vi40. (PMID:19617296). 10.1093/annonc/mdp254.
4. Salama A.K., Flaherty K.T. Clin. Cancer Res. 2013, 19(16):4326-4334. (PMID:23770823). 10.1158/1078-0432.CCR-13-0779.
5. Siroy A.E., Boland G.M., Milton D.R., Roszik J., Frankian S., Malke J., Haydu L., Prieto V.G., Tetzlaff M., Ivan D., et al. J. Invest. Dermatol. Aug 22 2014, (PMID:25148578, Epub ahead of print). 10.1038/jid.2014.366.
6. Nazarian R., Shi H., Wang Q., Kong X., Koya R.C., Lee H., Chen Z., Lee M.K., Attar N., Sazegar H., et al. Nature 2010, 468(7326):973-977. (PMID:21107323). 10.1038/nature09626.
7. Sherr C.J. Cell 2004, 116:235-246. (PMID:14744434).
8. Kastan M.B., Bartek J. Nature 2004, 432(7015):316-323. (PMID:15549093).
9. Levine A.J., Oren M. Nat. Rev. Cancer 2009, 9(10):749-758. (PMID:19776744). 10.1038/nrc2723.
10. Kellogg D.R. J. Cell Sci. 2003, 116(Pt 24):4883-4890. (PMID:14625382).
11. Harvey S.L., Charlet A., Haas W., Gygi S.P., Kellogg D.R. Cell 2005, 122(3):407-420. (PMID:16096060).
12. Sørensen C.S., Syljuåsen R.G. Nucleic Acids Res. 2012, 40(2):477-486. PMID:21937510. 10.1093/nar/gkr697.
13. Mak J.P., Man W.Y., Ma H.T., Poon R.Y. Oncotarget 2014, 5(21):10546-10557. (PMID:25301733).
14. Mir S.E., De Witt Hamer P.C., Krawczyk P.M., Balaj L., Claes A., Niers J.M., Van Tilborg A.A., Zwinderman A.H., Geerts D., Kaspers G.J., et al. Cancer Cell 2010, 18(3):244-257. (PMID:20832752). 10.1016/j.ccr.2010.08.011.
15. Wang Y., Decker S.J., Sebolt-Leopold J. Cancer Biol. Ther. 2004, 3(3):305-313. (PMID:14726685).
16. Tse A.N., Sheikh T.N., Alan H., Chou T.C., Schwartz G.K. Mol. Pharmacol. 2009, 75(1):124-133. (PMID:18820127). 10.1124/mol.108.050807.
17. Wang F., Zhu Y., Huang Y., McAvoy S., Johnson W.B., Cheung T.H., Chung T.K., Lo K.W., Yim S.F., Yu M.M., et al. Oncogene 2005, 24(24):3875-3885. (PMID:15735666).
18. Ma C.X., Janetka J.W., Piwnica-Worms H. Trends Mol. Med. 2011, 17(2):88-96. (PMID:21087899). 10.1016/j.molmed.2010.10.009.
19. Leach S.D., Scatena C.D., Keefer C.J., Goodman H.A., Song S.Y., Yang L., Pietenpol J.A. Cancer Res. 1998, 58(15):3231-3236. (PMID:9699647).
20. Gottifredi V., Karni-Schmidt O., Shieh S.S., Prives C. Mol. Cell. Biol. 2001, 21(4):1066-1076. (PMID:11158294).
21. Zenvirt S., Kravchenko-Balasha N., Levitzki A. Oncogene 2010, 29(46):6149-6159. (PMID:20729914). 10.1038/onc.2010.343.
22. Soengas M.S., Capodieci P., Polsky D., Mora J., Esteller M., Opitz-Araya X., McCombie R., Herman J.G., Gerald W.L., Lazebnik Y.A., et al. Nature 2001, 409:207-211. (PMID:11196646).
23. Saalbach A., Klein C., Schirmer C., Briest W., Anderegg U., Simon J.C. J. Invest. Dermatol. 2010, 130(2):444-454. (PMID:19710690). 10.1038/jid.2009.253.
24. van Vugt M.A., Brás A., Medema R.H. Mol. Cell 2004, 15(5):799-811. (PMID:15350223).
25. McKenzie L., King S., Marcar L., Nicol S., Dias S.S., Schumm K., Robertson P., Bourdon J.C., Perkins N., Fuller-Pace F., Meek D.W. Cell Cycle 2010, 9(20):4200-4212. (PMID:20962589).
26. Lieberman H.B. Curr. Med. Chem. 2008, 15(4):360-367. (PMID:18288990).
27. Zhou B.B., Bartek J. Nat. Rev. Cancer 2004, 4(3):216-225. (PMID:14993903).
28. Guillouf C., Rosselli F., Krishnaraju K., Moustacchi E., Hoffman B., Liebermann D.A. Oncogene 1995, 10(11):2263-2270. (PMID:7784074).
29. Macip S., Igarashi M., Berggren P., Yu J., Lee S.W., Aaronson S.A. Mol. Cell. Biol. 2003, 23(23):8576-8585. (PMID:14612402).
30. Abbas T., Dutta A. Nat. Rev. Cancer 2009, 9(6):400-414. (PMID:19440234). 10.1038/nrc2657.
31. Masgras I., Carrera S., de Verdier P.J., Brennan P., Majid A., Makhtar W., Tulchinsky E., Jones G.D., Roninson I.B., Macip S. J. Biol. Chem. 2012, 287(13):9845-9854. (PMID:22311974). 10.1074/jbc.M111.250357.
32. van Vugt M.A., Gardino A.K., Linding R., Ostheimer G.J., Reinhardt H.C., Ong S.E., Tan C.S., Miao H., Keezer S.M., Li J., et al. PLoS Biol. 2010, 8(1):e1000287. (PMID:20126263). 10.1371/journal.pbio.1000287.
33. Jalili A., Moser A., Pashenkov M., Wagner C., Pathria G., Borgdorff V., Gschaider M., Stingl G., Ramaswamy S., Wagner S.N. J. Invest. Dermatol. 2011, 131(9):1886-1895. (PMID:21654832). 10.1038/jid.2011.136.
34. Schmit T.L., Zhong W., Setaluri V., Spiegelman V.S., Ahmad N. J. Invest. Dermatol. 2009, 129(12):2843-2853. (PMID:19554017). 10.1038/jid.2009.172.
35. Owens L., Simanski S., Squire C., Smith A., Cartzendafner J., Cavett V., Caldwell Busby J., Sato T., Ayad N.G. J. Biol. Chem. 2010, 285(9):6761-6769. (PMID:20038582). 10.1074/jbc.M109.093237.
36. Bunz F., Dutriaux A., Lengauer C., Waldman T., Zhou S., Brown J.P., Sedivy J.M., Kinzler K.W., Vogelstein B. Science 1998, 282(5393):1497-1501. (PMID:9822382).
37. Syljuåsen R.G., Sørensen C.S., Hansen L.T., Fugger K., Lundin C., Johansson F., Helleday T., Sehested M., Lukas J., Bartek J. Mol. Cell. Biol. 2005, 25(9):3553-3562. (PMID:15831461).
38. Berkovich E., Monnat R.J., Kastan M.B. Nat. Cell Biol. 2007, 9(6):683-690. (PMID:17486112).
39. Jazayeri A., Falck J., Lukas C., Bartek J., Smith G.C., Lukas J., Jackson S.P. Nat. Cell Biol. 2006, 8(1):37-45. (PMID:16327781).
40. Reinhardt H.C., Yaffe M.B. Curr. Opin. Cell Biol. 2009, 21(2):245-255. (PMID:19230643). 10.1016/j.ceb.2009.01.018.
41. Shiotani B., Zou L. Mol. Cell 2009, 33(5):547-558. (PMID:19285939). 10.1016/j.molcel.2009.01.024.
42. Mukhopadhyay U.K., Senderowicz A.M., Ferbeyre G. Cancer Res. 2005, 65(7):2872-2881. PMID:15805289.
43. Beckerman R., Donner A.J., Mattia M., Peart M.J., Manley J.L., Espinosa J.M., Prives C. Genes Dev. 2009, 23(11):1364-1377. (PMID:19487575). 10.1101/gad.1795709.
44. Hirose Y., Berger M.S., Pieper R.O. Cancer Res. 2001, 61(15):5843-5849. (PMID:11479224).
45. Tao Y., Leteur C., Yang C., Zhang P., Castedo M., Pierré A., Golsteyn R.M., Bourhis J., Kroemer G., Deutsch E. Cell Cycle 2009, 8(8):1196-1205. (PMID:19305158).
46. Lossaint G., Besnard E., Fisher D., Piette J., Dulić V. Oncogene 2011, 30(41):4261-4274. (PMID:21532626). 10.1038/onc.2011.135.
47. Rodriguez R., Meuth M. Mol. Biol. Cell 2006, 17(1):402-412. (PMID:16280359).